immunocal glutathione randomized trial Clinical of How Long-Term Supplementation Offers Protection from Oxidative Damage and Improves HbA1c in Elderly Type 2 Diabetic Patients Therapeutic potential of glutathione-enhancers in
Description
H.HwangJ
Abstract Nuclear factor erythroid 2-related factor 2 (NRF2) is a stress responsive transcription factor that is mutationally activated in a subset (~25%) of clinically-aggressive non-small cell lung cancers (NSCLC)
The most frequent disorder in human is the glutathione synthetase (GSS) deficiency, which is often associated with hemolytic anemia, a clinical feature also present in -glutamylcysteine (GCLC) deficiency
10.1111/j.1365-2915.2009.00805.x 199 SarwarM.SalmanM
